Paydirt
MW
Insider

Matthew T. Wiley

Chief Commercial Officer

Matthew T. Wiley (Chief Commercial Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Definium Therapeutics, Inc. (DFTX). The largest single filing was $129K of DFTX (2,867 sh × $45.03, as filed), executed Jun 25.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$129K
shares × price, as filed
Last traded
Jun 25
Filed Jun 26

Median ADV $136.1M across their filed names

Open performance→
Volume by month
$129K$65K$0Oct 2024Apr 2025Oct 2025Apr 2026Jun 2026 · sells $129K
Buys $0 Sells $129K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names
DFTX Definium Therapeutics, Inc. DFTX · 0 buys · 1 sell 1 filing
Recent filings
DFTXSALE Definium Therapeutics, Inc. View filing → $129K
2,867 sh × $45.03
Exec Jun 25
Filed Jun 26 · 5:30 PM ET